Ulanghutan, Muhammad Rhyadh T.

HRN: 26-53-63  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2025
ACICLOVIR 400MG (TAB)
05/30/2025
06/06/2025
PO
160mg/pptab 1pptab
Q6
Varicella Infection
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: